Product Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Extended-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical and physical stability of the controlled-release polymer.
| Active Ingredient | Strength | Primary Clinical Function |
|---|
Desvenlafaxine Succinate USP/Ph.Eur.
(Equivalent to Desvenlafaxine base) | 50 mg (ER) | The Global Therapeutic Standard: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients suffering from Major Depressive Disorder. |
| Desvenlafaxine Succinate USP/Ph.Eur. | 100 mg (ER) | The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for severe, treatment-resistant depression where maximum norepinephrine reuptake inhibition is required. |
| Excipients | Hypromellose (HPMC) / Microcrystalline Cellulose / Talc / Magnesium Stearate / Premium Polymeric Film | Hydrophilic ER Matrix / Diluent / Glidant / Lubricant / Film-Coating (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastric fluid, the tablet forms a thick, gelatinous outer layer that slowly erodes over 24 hours, guaranteeing a smooth, flat pharmacokinetic curve to prevent violent nausea and serotonin spikes) |
*Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day psychiatric dispensing regimens).